What is voriconazole?
Voriconazole is anprescription medicine approved by the U.S. (FDA) for the treatment of certain fungal infections, such as esophageal of the esophagus) and candidiasis.
Esophageal candidiasis and invasive candidiasis can be What is an Opportunistic Infection? fact sheet.(OIs) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo
How is voriconazole used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV and the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV include recommendations on the uses of voriconazole to:
- Candidiasis, including esophageal candidiasis and invasive candidiasis
- Coccidioidomycosis from recurring
- Histoplasmosis from recurring
The recommended uses may not always be consistent with FDA-approved uses of voriconazole. See the Adult and Pediatric Opportunistic Infection Guidelines for complete information on recommended uses of voriconazole in adults and children with HIV. Voriconazole may have other recommended uses not listed above.
What should I tell my health care provider before using voriconazole?
Before using voriconazole, tell your health care provider:
- If you are allergic to voriconazole or any other medicines.
- About any medical conditions you have or have had, including:
- Low levels of potassium, magnesium, or calcium.
- If you have trouble digesting dairy products, milk sugar (lactose), or table sugar.
- About anything that could affect your ability to take medicines, such as difficulty swallowing pills, difficulty remembering to take pills, or any health conditions that may prevent your use of medicines.
- If you are pregnant or plan to become pregnant. Voriconazole can harm your unborn baby. Talk to your health care provider about the risks with using voriconazole during pregnancy. The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV may include other recommendations on the use of voriconazole during pregnancy. Please refer to these guidelines for additional information.
- If you are breastfeeding or plan to breastfeed. For women with HIV in the United States, the Guideline does not recommend breastfeeding. Before your baby is born, or if you are already breastfeeding, talk to your health care provider to discuss alternative options for feeding your baby.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Voriconazole may affect the way other medicines or products work, and other medicines or products may affect how voriconazole works. Ask your health care provider if there are interactions between voriconazole and the other medicines you take.
Ask your health care provider about possible side effects from voriconazole. Your health care provider will tell you what to do if you have side effects.
How should I use voriconazole?
Use voriconazole according to your health care provider’s instructions. Your health care provider will tell you how much voriconazole to use and when to use it. Before you start voriconazole and each time you get a refill, read any printed information that comes with your medicine.
How should voriconazole be stored?
- Store unopened vials of voriconazole for injection at 59°F to 86°F (15°C to 30°C). Once the injection powder in the vial has been reconstituted with Water for Injection, the solution should be used immediately. Only clear solution without particles should be used.
- Store voriconazole tablets at 59°F to 86°F (15°C to 30°C).
- Store voriconazole powder for oral suspension in a refrigerator at 36°F to 46°F (2°C to 8°C) before reconstitution. After reconstitution, the oral suspension should be stored at 59°F to 86°F (15°C to 30°C). Do not refrigerate or freeze it. Any remaining oral suspension should be thrown away 14 days after reconstitution.
- Keep voriconazole in the container that it came in and keep the container tightly closed.
- Do not use voriconazole if the original seal over the container opening is broken or missing.
- Throw away voriconazole that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep voriconazole and all medicines out of reach of children.
Where can I find more information about voriconazole?
- Recommendations on the HIV-related uses of voriconazole, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV and the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV.
- This Patient Version drug summary is based on the following FDA label(s): Tablet (film coated), injection (powder, lyophilized, for solution), powder (for suspension). The Patient Package Insert and Instructions For Use include information for people taking voriconazole.
- The American Hospital Formulary Service (AHFS) Patient Medication Information for voriconazole is available from MedlinePlus.
- Voriconazole-related research studies, from . (The ClinicalTrials.gov search can be modified so that you can get results that better match your interests. To learn more about the ClinicalTrials.gov search features, please see How to Search.)
Last Reviewed: November 12, 2021